Hiroaki Dobashi - Concepedia

Author

Hiroaki Dobashi

Also Known As

Dobashi, Hiroaki, H Dobashi, H. Dobashi, HIROAKI DOBASHI, Haner Direskeneli, Hiroaki DOBASHI, Hiroaki Dobashi, Hiroki Dobashi, Takao Fujii

269

Publications

3.8K

Citations

H-Index

129

Concepts

All Affiliations

Kagawa University Tokyo Medical and Dental University Saitama Medical University University of Tsukuba Kyorin University

About

Hiroaki Dobashi is an author at Kagawa University specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	29	1.3K
2	Health Sciences	4	4	133
3	Allergy	3	3	102
4	Engineering	1	1	69
5	Public Health	1	1	10

Hiroaki Dobashi

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados, The Lancet InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseSpondyloarthritis	2018	349
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler, The Lancet RheumatologySpondyloarthritisRheumatic DiseasesPlacebo-controlled TrialInflammatory Rheumatic Disease	2019	208
Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study Ken‐ei Sada, Masahiro Yamamura, Masayoshi Harigai, Arthritis Research & Therapy	2014	206
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials Désirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, Annals of the Rheumatic Diseases	2023	96
Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients Tomohiro Kameda, Hiroaki Dobashi, Nobuyuki Miyatake, Arthritis Care & Research	2014	93
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease Yasufumi Masaki, Shoko Matsui, Takako Saeki, Modern Rheumatology	2016	85
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan Frank B. Cortazar, John L. Niles, David Jayne, Kidney International Reports	2023	77
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry Ryoko Sakai, Soo‐Kyung Cho, Toshihiro Nanki, Arthritis Research & Therapy Rheumatoid DisorderRheumatologyEpidemiologyMedicineRheumatic Diseases	2015	72
Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis Takashi Norikane, Yuka Yamamoto, Yukito Maeda, EJNMMI Research	2017	70
[18F]Fluorodeoxyglucose Positron Emission Tomography Imaging in a Case of Relapsing Polychondritis Yoshihiro Nishiyama, Yuka Yamamoto, Hiroaki Dobashi, Journal of Computer Assisted Tomography Computed TomographyAsthmaEngineeringPet-mriAdvanced Imaging	2007	69

Page 1